Prevention of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)1

Thrombosis Research

Volumn 129, Issue 5, 2012, Pages

  Siragusa, Sergio ^a   Armani, Ugo ^k   Carpenedo, Monica ^c   Falanga, Anna ^g   Fulfaro, Fabio ^a   Imberti, Davide ^d   Laurora, Renzo ⁱ   Molinari, Angelo Claudio ^h   Prisco, Domenico ^e   Silingardi, Mauro ^j   Verso, Melina ^f   Visonà, Adriana ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b SSD Angiologia   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF FLORENCE   (Italy)

^f SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^g OSPEDALI RIUNITI   (Italy)

^h G GASLINI INSTITUTE   (Italy)

ⁱ AULSS   (Italy)

^j Ospedale di Reggio Emilia   (Italy)

^k UNIVERSITY OF GENOA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PLACEBO; WARFARIN;

ABDOMINAL SURGERY; ANTICOAGULATION; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CENTRAL VENOUS CATHETER; DRUG EFFICACY; HEMOSTASIS; HOSPITALIZATION; HUMAN; MAJOR SURGERY; PELVIS SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 84860437360     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.09.002     Document Type: Article

References (53)

1. J.W. Blom, J.P. Vanderschoot, M.J. Oostindier, S. Osanto, F.J. van der Meer, and F.R. Rosendaal Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 2006 529 535
2. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
3. D.M. Monroe, and M. Hoffman Dysregulation of hemostasis by cancer Cancer Treat Res 148 2009 3 15
4. A. Aharon, and B. Brenner Microparticles, thrombosis and cancer Best Pract Res Clin Haematol 22 1 2009 Mar 61 69
5. N. Horowitz, and B. Brenner Thrombophilia and cancer Pathophysiol Haemost Thromb 36 3-4 2008 131 136
6. P.A. Thodiyil, and A.K. Kakkar Variation in relative risk of venous thromboembolism in different cancers Thromb Haemost 87 2002 1076 1077
7. A.A. Khorana, C.W. Francis, E. Culakova, R.I. Fisher, N.M. Kuderer, and G.H. Lyman Thromboembolism in hospitalized neutropenic cancer patients J Clin Oncol 24 2006 484 490
8. P.D. Stein, A. Beemath, F.A. Meyers, E. Skaf, J. Sanchez, and R.E. Olson Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 2006 60 68
9. T.C. Haddad, and E.W. Greeno Chemotherapy-induced thrombosis Thromb Res 118 2006 555 568
10. G. Agnelli, G. Bolis, L. Capussotti, R.M. Scarpa, F. Tonelli, and E. Bonizzoni A clinical outcome based prospective study on venous thromboembolism after cancer surgery: the ARISTOS project Ann Surg 243 2006 89 95
11. A.Y. Lee, M.N. Levine, G. Butler, C. Webb, L. Costantini, and C. Gu Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer J Clin Oncol 24 2006 1404 1408
12. E.A. Akl, G. Karmath, V. Yosuico, S.Y. Kim, M. Barba, and F. Sperati Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters Cochrane Database Syst Rev 18 3 2007 Jul
13. A. Iorio, W. Ageno, B. Cosmi, D. Imberti, F. Lussana, and S. Siragusa Objectives and methodology: Guidelines of the Italian Society for Haemostasis and Thrombosis Thromb Res 124 2009 e1 e5
14. Scottish Intercollegiate Guidelines Network, SIGN 50: A guideline developers' handbook, SIGN Publication No. 50. February 2001, last updated May 2004. Available from: http://www.sign.ac.uk.
15. M.M. Samama, A.T. Cohen, J.Y. Darmon, L. Desjardins, A. Eldor, and C. Janbon A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients: Prophylaxis in Medical Patients with Enoxaparin Study Group N Engl J Med 341 1999 793 800
16. A. Leizorovicz, A.T. Cohen, and A.G. Turpie Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 2004 874 879
17. A.T. Cohen, B.L. Davidson, A.S. Gallus, M.R. Lassen, M.H. Prins, and W. Tomkowski Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Randomised placebo controlled trial BMJ 332 2006 325 329
18. R. Alikhan, A.T. Cohen, S. Combe, M.M. Samama, L. Desjardins, and A. Eldor Prevention of venous thromboembolism in medical patients with enoxaparin: A subgroup analysis of the MEDENOX study Blood Coagul Fibrinolysis 14 2003 341 346
19. B. Gardlund Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases: The Heparin Prophylaxis Study Group Lancet 347 1996 1357 1361
20. P. Mismetti, S. Laporte-Simitsidis, B. Tardy, J. Reynaud, P. Mahul, and P. Mismetti Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecularweight heparins: A meta-analysis of randomised clinical trials Thromb Haemost 83 2000 14 19
21. L.D. Wagman, M.F. Baird, C.L. Bennett, P.L. Bockenstedt, S.R. Cataland, and J. Fanikos National Comprehensive Cancer Network. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology J Natl Compr Canc Netw 6 8 2008 Sep 716 753
22. M. Mandalà, A. Falanga, F. Roila, and ESMO Guidelines Working Group Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management Ann Oncol 21 Suppl 5 2010 v274 v276
23. M. Mandala, A. Falanga, A. Piccioli, P. Prandoni, E.M. Pogliani, and R. Labianca working group AIOM. Venous thromboembolism and cancer: guidelines of the Italian Association of Medical Oncology (AIOM) Crit Rev Oncol Hematol 59 2006 194 204
24. G.H. Lyman, A.A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, and M. Jahanzeb American Society of Clinical Oncology. American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 2007 5490 5505
25. W.H. Geerts, D. Bergqvist, G.F. Pineo, J.A. Heit, C.M. Samama, and M.R. Lassen Prevention of Venous Thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 381 453
26. A.K. Kakkar, and R.C. Williamson Thromboprophylaxis in malignant disease Br J Surg 82 1995 724 725
27. M.J. Leonardi A systematic review of deep venous thrombosis prophylaxis in surgical oncology Am J Hematol Oncol 6 8 2007 446 450
28. G. Agnelli, D. Bergqvist, A.T. Cohen, A.S. Gallus, M. Gent, and PEGASUS investigators Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery Br J Surg 92 2005 1212 1220
29. D. Bergqvist, G. Agnelli, A.T. Cohen, A. Eldor, P.E. Nilsson, and A.A. Le-Moigne Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer New Engl J Med 346 2002 975 980
30. M.S. Rasmussen, L.N. Jorgensen, P. Wille-Jorgensen, J.D. Nielsen, A. Horn, and A.C. Mohn Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: A multicenter randomized open-label study J Thromb Haemost 4 2006 2384 2390
31. F.P. Secin, T. Jiborn, A.S. Bjartell, G. Fournier, L. Salomon, and C.C. Abbou Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy Eur Urol 53 2008 Jan 134 145
32. G.P. Clagett, and J.S. Reisch Prevention of venous thromboembolism in general surgical patients: Results of meta-analysis Ann Surg 208 1998 227 240
33. P. Wille-Jorgensen, M.S. Rasmussen, and B.R. Andersen Heparins and mechanical methods for thromboprophylaxis in colorectal surgery Cochrane Database Syst Rev 4 2003 CD001217
34. M. Levine, J. Hirsh, M. Gent, A. Arnold, D. Warr, and A. Falanga Double-blind randomized trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer Lancet 343 1994 886 889
35. S.K. Haas Prevention of venous thromboembolism with low-molecular-weight heparin in patients with metastatic breast or lung cancer: Results of the TOPIC Studies J Thromb Haemost 3 suppl 1 2005 abstr OR059
36. M. Cavo, E. Zamagni, C. Cellini, P. Tosi, D. Cangini, and M. Cini Deep vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy Blood 100 2002 2272 2273
37. S.V. Rajkumar, E. Blood, D. Vesole, R. Fonseca, and P.R. Greipp Eastern Cooperative Oncology Group. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: A clinical trial coordinated by the Eastern Cooperative Oncology Group J Clin Oncol 24 2006 431 436
38. M. Zangari, E. Anaissie, B. Barlogie, A. Badros, R. Desikan, and A.V. Gopal Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy Blood 98 2001 1614 1615
39. C.L. Bennett, C. Angelotta, P.R. Yarnold, A.M. Evens, J.A. Zonder, and D.W. Raisch Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer JAMA 296 2006 2558 2560
40. R.N. El Accaoui, W.A. Shamseddeen, and A.T. Taher Thalidomide and thrombosis: a meta-analysis Thromb Haemost 97 2007 1031 1036
41. A. Palumbo, C. Rus, J.B. Zeldis, F. Rodeghiero, M. Boccadoro, and Italian Multiple Myeloma Network, Gimema Enoxaparin or aspirin for the prevention of recurrent thromboembolism in newly diagnosed myeloma patients treated with melphalan and prednisone plus thalidomide or lenalidomide J Thromb Haemost 4 2006 1842 1845
42. A. Palumbo, M. Cavo, S. Bringhen, M. Cavalli, F. Patriarca, and D. Rossi A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens Blood 114 2009 492
43. M. Zangari, B. Barlogie, E. Anaissie, F. Saghafifar, P. Eddlemon, and J. Jacobson Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation Br J Haematol 126 2004 715 721
44. S.V. Rajkumar, S.R. Hayman, M.Q. Lacy, A. Dispenzieri, S.M. Geyer, and B. Kabat Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma Blood 106 2005 4050 4053
45. F. Cavallo, F. Di Raimondo, I. Harda, B. Lupo, A. Romano, and L. Catalano A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen Blood 116 2010 1092
46. G. Agnelli, G. Gussoni, C. Bianchini, M. Verso, M. Mandalà, and L. Cavanna Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study Lancet Oncol 10 10 2009 943 949
47. M.E. Tesselaar, J. Ouwerkerk, M.A. Nooy, F.R. Rosendaal, and S. Osanto Risk factors for catheter-related thrombosis in cancer patients Eur J Cancer 40 2004 2253 2259
48. A. Cortelezzi, N.S. Fracchiolla, P. Maisonneuve, M. Moia, C. Luchesini, and M.L. Ranzi Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures Leuk Lymphoma 44 2003 1495 1501
49. A. Abdelkefi, O.T. Ben, L. Kammoun, M. Chelli, N.B. Romdhane, and A. Kriaa Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial Thromb Haemost 92 2004 654 661
50. M. Karthaus, A. Kretzschmar, H. Kroning, M. Biakhov, D. Irwin, and N. Marschner Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: Final results of a double-blind, placebo-controlled phase III trial Ann Oncol 17 2 2006 289 296
51. T.M.H. Niers, M. Di Nisio, C.P.W. Klerk, H.J. Baarslag, H.R. Buller, and B.J. Biemond Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: A randomized, placebo-controlled study J Thromb Haemost 5 9 2007 1878 1882
52. A. Chan, A. Iannucci, and W.E. Dager Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients Ann Pharmacother 41 2007 635 641
53. P. Debourdeau, D. Kassab Chahmi, G. Le Gal, I. Kriegel, E. Desruennes, and M.C. Douard French National Feberation of Cancer Centers. 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group Ann Oncol 20 9 2009 Sep 1459 1471